Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Cryo Cell International (CCEL) Short-Term Debt repayments (2022 - 2026)

Cryo Cell International's Short-Term Debt repayments history spans 5 years, with the latest figure at $1.9 million for Q1 2026.

  • Quarterly results put Short-Term Debt repayments at $1.9 million for Q1 2026, up 8.57% from a year ago — trailing twelve months through Feb 2026 was $10.2 million (up 127.38% YoY), and the annual figure for FY2025 was $10.0 million, up 242.83%.
  • Short-Term Debt repayments for Q1 2026 was $1.9 million at Cryo Cell International, down from $2.9 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $5.4 million in Q4 2022 to a low of $200000.0 in Q1 2024.
  • The 5-year median for Short-Term Debt repayments is $1.9 million (2026), against an average of $2.0 million.
  • The sharpest move saw Short-Term Debt repayments crashed 72.22% in 2023, then surged 775.0% in 2025.
  • Year by year, Short-Term Debt repayments stood at $5.4 million in 2022, then crashed by 72.22% to $1.5 million in 2023, then tumbled by 51.82% to $722728.0 in 2024, then skyrocketed by 301.26% to $2.9 million in 2025, then crashed by 34.48% to $1.9 million in 2026.
  • According to Business Quant data, Short-Term Debt repayments over the past three periods came in at $1.9 million, $2.9 million, and $3.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.